Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Liu Tianshi

From Bioblast
(Redirected from Liu T)
Name Liu Tianshi, PhD
Institution
Tianshi Liu

Lund University,

Mitochondrial Medicine, SE

Address BMC A13, Sรถlvegatan 17, SE-221 84
City Lund
State/Province
Country Sweden
Email tianshi.liu@med.lu.se
Weblink
O2k-Network Lab

Participated at


Labels:



Publications

 PublishedReference
Shao 2019 Cardiovasc Diabetol2019Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T (2019) Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induce diabetic rats. Cardiovasc Diabetol 18:165.
Zhang 2018 Cardiovasc Diabetol2018Zhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T (2018) Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 17:160.
Zhang 2017 J Am Heart Assoc2017Zhang X, Zhang Z, Zhao Y, Jiang N, Qiu J, Yang Y, Li J, Liang X, Wang X, Tse G, Li G, Liu T (2017) Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits. J Am Heart Assoc 6:e005945.

Abstracts

Add abstract